Survival in borderline resectable and locally advanced pancreatic cancer is determined by the duration and response of neoadjuvant therapy

Publication date: Available online 30 April 2021Source: European Journal of Surgical OncologyAuthor(s): Asanka R. Wijetunga, Terence C. Chua, Christopher B. Nahm, Nick Pavlakis, Stephen Clarke, David L. Chan, Connie Diakos, Sarah Maloney, Amir Ashrafi-Zadeh, Andrew Kneebone, George Hruby, Nigel B. Jamieson, Anthony Gill, Anubhav Mittal, Jaswinder S. Samra
Source: European Journal of Surgical Oncology (EJSO) - Category: Surgery Source Type: research